The 1 Thing I'll be Looking for in Moderna's Earnings Report Next Week

Moderna's (NASDAQ: MRNA) last earnings report was chock-full of good surprises. The company announced its first-ever profit, which surpassed $1 billion, thanks to Moderna's single product: the coronavirus vaccine. The company expects more than $19 billion in vaccine sales this year and reported progress on vaccine orders for next year, too.

After all of that, what more could we possibly expect in Moderna's next earnings report? Well, Moderna likely will update its vaccine revenue expectations for the year, and investors will surely have an eye on the company's profit level.

Those elements are key. But the most important thing I'll be looking for in Moderna's earnings report next week has to do with a subject most of us have been talking about in recent weeks. And that is... drum roll, please...

Source Fool.com